Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Newbury Pharmaceuticals AB | P52 | Sep 20, 2024 | 0.20 | -2.01 |
Newcap Holding | 25N | Sep 20, 2024 | 0.02 | 0.00 |
Newcore Gold Ltd. | PI8 | Sep 20, 2024 | 0.21 | +0.48 |
Newell Brands Inc. | NWL | Sep 20, 2024 | 6.62 | +0.88 |
NEWFIELD RESOURCES LTD | 4XK0 | Sep 20, 2024 | 0.06 | 0.00 |
NEWFOUNDLAND DISCOV.CORP. | M4K | Sep 20, 2024 | 0.00 | 0.00 |
NewJersey Resources Corporation | NJ1 | Sep 20, 2024 | 42.60 | -0.47 |
Newlat Food S.p.a. | 6NF | Sep 20, 2024 | 11.38 | -1.39 |
Newlox Gold Ventures Corp | NGO | Sep 20, 2024 | 0.06 | 0.00 |
Newmark Group, Inc. - Class A | NMB | Sep 20, 2024 | 13.50 | 0.00 |
Newmark Security plc | NN10 | Sep 20, 2024 | 1.06 | +0.95 |
NewMarket Corp. | UG9 | Sep 20, 2024 | 492.00 | +0.41 |
NEWMONT CORP.CDI | NMM0 | Sep 20, 2024 | 48.60 | +2.10 |
Newmont Corporation | NMM | Sep 20, 2024 | 48.40 | +0.95 |
Newpark Resources, Inc. | NWP | Sep 20, 2024 | 6.70 | +3.08 |
Newron Pharmaceuticals Spa. | NP5 | Sep 20, 2024 | 8.95 | +14.74 |
News Corp | NC0E | Sep 20, 2024 | 24.80 | 0.00 |
News Corporation - Class A | NC0 | Sep 20, 2024 | 23.40 | -1.68 |
News Corporation - Class B | NC0B | Sep 20, 2024 | 24.40 | +2.52 |
Newtek Business Services Corp. | 1N31 | Sep 20, 2024 | 10.43 | +0.10 |
NEWTON RES | 8NW | Sep 20, 2024 | 0.04 | 0.00 |
Nexa Resources S.A. | NE0 | Sep 20, 2024 | 5.95 | -0.83 |
Nexam Chemical Holding | NC4 | Sep 20, 2024 | 0.37 | -0.27 |
NEXANS ADR EO 1 | NXS0 | Sep 20, 2024 | 64.50 | +3.20 |
Nexans SA | NXS | Sep 20, 2024 | 130.90 | -1.58 |
NEXE Innovations Inc | NX5 | Sep 20, 2024 | 0.21 | +8.67 |
NexGen Energy Ltd | 6NEA | Sep 20, 2024 | 4.98 | +2.05 |
NexGen Energy Ltd | 6NE | Sep 20, 2024 | 5.68 | +8.40 |
NEXI S.P.A. Unsponsored ADR (Italy) | N0X0 | Sep 20, 2024 | 6.05 | -1.63 |
Nexi SpA | N0XA | Sep 20, 2024 | 6.41 | +0.98 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.